These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 17645424)
1. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424 [TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. Loftsson T; Hreinsdóttir D; Stefánsson E J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227 [TBL] [Abstract][Full Text] [Related]
3. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer. Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511 [TBL] [Abstract][Full Text] [Related]
4. Tissue distribution of dexamethasone in canine ocular compartments following topical application of dexamethasone-21-isonicotinate and oxytetracycline HCl. Kaiser T; Werner A; Bäumer W; Kietzmann M Vet Ophthalmol; 2008; 11(5):335-9. PubMed ID: 19046294 [TBL] [Abstract][Full Text] [Related]
5. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye. Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Ghate D; Brooks W; McCarey BE; Edelhauser HF Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284 [TBL] [Abstract][Full Text] [Related]
9. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants. Okabe K; Kimura H; Okabe J; Ogura Y Retina; 2007; 27(6):770-7. PubMed ID: 17621189 [TBL] [Abstract][Full Text] [Related]
10. Influence of peripheral iridectomy on intravitreous penetration of topical nipradilol. Mayama C; Tomidokoro A; Araie M; Mizuno K Curr Eye Res; 2004 Feb; 28(2):129-33. PubMed ID: 14972718 [TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics profile of different indomethacin topical formulations. Bucolo C; Melilli B; Piazza C; Zurria M; Drago F J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858 [TBL] [Abstract][Full Text] [Related]
12. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Behar-Cohen FF; Parel JM; Pouliquen Y; Thillaye-Goldenberg B; Goureau O; Heydolph S; Courtois Y; De Kozak Y Exp Eye Res; 1997 Oct; 65(4):533-45. PubMed ID: 9464186 [TBL] [Abstract][Full Text] [Related]
13. Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina. Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2839-47. PubMed ID: 19218605 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma. Hayden BC; Jockovich ME; Murray TG; Voigt M; Milne P; Kralinger M; Feuer WJ; Hernandez E; Parel JM Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3644-9. PubMed ID: 15452072 [TBL] [Abstract][Full Text] [Related]
16. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612 [TBL] [Abstract][Full Text] [Related]
17. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration. Holló G; Whitson JT; Faulkner R; McCue B; Curtis M; Wieland H; Chastain J; Sanders M; DeSantis L; Przydryga J; Dahlin DC Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001 [TBL] [Abstract][Full Text] [Related]
20. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Pleyer U; Lutz S; Jusko WJ; Nguyen KD; Narawane M; Rückert D; Mondino BJ; Lee VH; Nguyen K Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2737-42. PubMed ID: 7688360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]